Key result
Endomyocardial biopsy aids diagnosis and prognosis of ICI myocarditis when non-invasive tests are uncertain.
Why the study?
The role of endomyocardial biopsy in the diagnosis, prognostication, and understanding of mechanisms for immune checkpoint inhibitor myocarditis needed to be identified.
Does endomyocardial biopsy improve the diagnosis and prognostication of immune checkpoint inhibitor associated myocarditis in patients receiving immune checkpoint inhibitors?
Does endomyocardial biopsy improve the diagnosis and prognostication of immune checkpoint inhibitor associated myocarditis in patients receiving immune checkpoint inhibitors?
Answers are grounded in this paper and cite their sources.
Endomyocardial biopsy provides definitive diagnostic and emerging prognostic value in immune checkpoint inhibitor myocarditis, particularly when non-invasive imaging is inconclusive.
To identify the role of endomyocardial biopsy in the diagnosis, prognostication, and future understanding of mechanisms for immune checkpoint inhibitor myocarditis. The use of endomyocardial biopsy in immune checkpoint inhibitor myocarditis has led to recognizing a spectrum of disease that correlates with mild symptoms to more fulminant presentations. The primary infiltrate observed is CD8+ T cells but more studies are suggesting that the presence of CD68+ macrophages may portend worse prognosis. Currently, endomyocardial biopsy still has a role in diagnosing immune checkpoint inhibitor myocarditis especially when there is uncertainty from non-invasive diagnostic tools. Emerging evidence suggests endomyocardial biopsy can help with prognosis determination and potentially even guide future cancer therapy. Future research into understanding mechanisms of immune checkpoint inhibitor myocarditis will require endomyocardial biopsy for tissue acquisition.
No takes yet. Share an insight, caveat, or question.
Ostos-Mendoza et al. (2026) conducted a review in Immune checkpoint inhibitor associated myocarditis. Endomyocardial biopsy was evaluated. Endomyocardial biopsy remains valuable for diagnosing immune checkpoint inhibitor myocarditis when non-invasive tests are uncertain, and emerging evidence suggests it can help determine prognosis.
Synapse has enriched 10 related papers. Consider them for comparative context: